Diseases & Disorders
(G50)
IRS Verified
DX Registered
990 on File
FACIAL PAIN RESEARCH FOUNDATION INC
Financial strength (30%)
82/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The FPRF is the only organization in the world dedicated solely to funding research that will cure neuropathic facial pain, often classified as the “worst pain known to mankind.” It is an all-volunteer group, that puts over 95 cents of every dollar that comes in directly towards research. Since its inception over 12 years ago, FPRF has raised over $5.5-million to fund eight distinct research programs to find the cures. It has helped create two venture capitalized corporations. The $5.5-million served in a multiplier capacity resulting in almost $50 million in venture capital, NIH, or other Foundation funding for research.
Financial Overview — FY 2025
$958K
Total Revenue
$342K
Total Expenses
$2.8M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.0%
Fundraising Efficiency
43.3%
Operating Reserve
96.49x
Liability-to-Asset
0.0%
Revenue Diversification
91.4%
Executive Compensation
$0
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.0% | 83.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
19.4% | 10.0% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.6% | 0.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
43.3% | 15.8% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
96.5 mo | 11.9 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.6% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
91.4% | 93.4% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-1.4% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-26.2% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
64.3% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $958K | $342K | $2.8M | 77.0% | 0 |
| 2024 | $971K | $463K | $2.1M | 96.5% | 0 |
| 2023 | $795K | $303K | $1.6M | 89.5% | 0 |
| 2022 | $1.4M | $499K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.